14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Feb 28, 2024 Buy 0 Ramsay Mary Beth
Feb 28, 2024 Buy 0 Nelson James N Iii
Jan 01, 2024 Buy 0 Forrester Michael A
Jan 01, 2024 Buy 0 Starr Loren M
Jan 01, 2024 Buy 0 Kenny Thomas J
Jan 01, 2024 Buy 0 Boateng Joseph A
Aug 04, 2022 Buy 0 Stenersen Trey Iii
Jun 01, 2022 Buy 0 Black Brett
Apr 14, 2022 Buy 0 Mccann John M.
Nov 30, 2021 Sell 1 000 Zimmerman Gifford R Common Stock
Jun 02, 2021 Buy 0 Medero Joanne
Jun 02, 2021 Buy 0 Lancellotta Amy B.r.
Nov 16, 2020 Buy 0 Thornton Matthew Iii
Nov 10, 2020 Buy 1 000 Zimmerman Gifford R Common Stock
Aug 03, 2020 Buy 0 Campagna Philip James
Aug 03, 2020 Buy 0 Liao Lei
Aug 03, 2020 Buy 0 Tran Darren
Feb 27, 2020 Buy 0 Morgan Deann
Oct 07, 2019 Buy 0 Meissner Jon Scott
Aug 08, 2019 Buy 0 Longerstaey Jacques M
Aug 08, 2019 Buy 0 Lockhart Brian J
Apr 12, 2019 Buy 0 Wickerham E. Scott
Aug 08, 2018 Buy 0 Huffman William T. Jr.
Aug 08, 2018 Buy 0 Hrazanek Jody I
Feb 28, 2018 Buy 0 Winget Demark L
Feb 28, 2018 Buy 0 Meyers William T.
Aug 02, 2017 Buy 0 Siffermann William A
Aug 02, 2017 Buy 0 Perry Michael A
Aug 02, 2017 Buy 0 Hembre Keith
Aug 02, 2017 Buy 0 Friar David
Jul 01, 2017 Buy 0 Robert Young L
May 17, 2017 Sell 1 Nuveen Fund Advisors, Llc Common Stock
Oct 01, 2016 Buy 0 Rohrbacher Christopher M.
Jul 01, 2016 Buy 0 Moschner Albin F
Jun 15, 2016 Buy 0 Jones Nathaniel T.
Feb 15, 2016 Buy 0 Wolff Margaret L.
Aug 06, 2015 Buy 0 Hlavacek Sherri A
Feb 24, 2015 Buy 0 Lamb David J
Dec 22, 2014 Buy 0 Toth Terence J
Dec 22, 2014 Buy 0 Stringer Virginia
Dec 22, 2014 Buy 0 Nuveen Fund Advisors, Llc Common Stock
Dec 22, 2014 Buy 0 Stone Carole E
Dec 22, 2014 Buy 0 Zimmerman Gifford R
Dec 22, 2014 Buy 0 Stockdale Judith M
Dec 22, 2014 Buy 0 Slager Joel T.
Dec 22, 2014 Buy 0 Schreier Thomas S Jr
Dec 22, 2014 Buy 0 Schneider William J
Dec 22, 2014 Buy 0 Prudhomme Kathleen L
Dec 22, 2014 Buy 0 Nelson John Kevin
Dec 22, 2014 Buy 0 Mccarthy Kevin J
Dec 22, 2014 Buy 0 Kundert David J
Dec 22, 2014 Buy 0 Kelly Walter M
Dec 22, 2014 Buy 0 Hunter William Curt
Dec 22, 2014 Buy 0 Foy Stephen D
Dec 22, 2014 Buy 0 Ferguson Lorna C
Dec 22, 2014 Buy 0 Evans Jack
Dec 22, 2014 Buy 0 Cook Margo L.
Dec 22, 2014 Buy 0 Bremner Robert P
Dec 22, 2014 Buy 0 Antosiewicz Cedric H
Dec 22, 2014 Buy 0 Adams William Iv
INSIDER POWER
0
Last 60 transactions
Buy: 1 000 | Sell: 1 001 (Shares)

Based on the 60 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 1 000 and sold 1 001 DIAX shares in the last 60 trades.

Click to get the best stock tips daily for free!

About Nuveen Dow 30SM Dynamic Overwrite Fund

Nuveen Dow 30 Dynamic Overwrite Fund is a closed-ended equity mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in stocks of large cap companies. The fund also invests through call options. It seek... DIAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT